Our company has transformed from Evolve Biosystems® to Infinant Health™. Learn More.
Antibiotic resistant infant

Your Infant Patients vs. Antibiotic Resistance

Antibiotic resistance is a global health epidemic

  • According to the World Health Organization, 200,000 infants die each year as a result of antibiotic resistance55
  • By 2050, an estimated 10 million deaths annually will result from antibiotic resistance – more than the forecasted death rate of cancer56

REQUEST MORE INFORMATION

Globally, 40% of newborn infections are resistant to standard antibiotic treatment indicating a reservoir of antibiotic-resistant genes in this population.55 These babies can become vectors of antibiotic-resistant genes, spreading bacteria to family members and playmates. We are looking at a global epidemic. It is time to take preventative action for your patients now.

What can be done to address the antibiotic-resistant crisis? Given your infant patients' immune system is rapidly developing in their first six months of life, it is important to take swift, effective steps to reduce antibiotic resistance in the microbiome. The first step is Evivo. Evivo® (activated B. infantis EVC001, Actibif®) in combination with human milk, is the only clinically-proven infant probiotic of its kind to fight against antibiotic resistance.

Evivo baby probiotics make Mom happy and keep baby healthy

The Best Defense Against Antibiotic-Resistance Genes (ARGs) is Evivo.

In a recently published clinical study, infants fed Evivo had lower total levels of ARGs in the gut microbiome.58 Evivo works with breast milk to suppress the growth of potentially pathogenic bacteria that harbor the genes responsible for antibiotic resistance.

  • 90% reduction in ARGs
  • Near elimination of bacteria such as Escherichia, Staphylococcus, and Clostridium
  • Lowers the pH in the infant gut, making it difficult for antibiotic-resistant bacteria to thrive
Evivo with MCT Oil

How can you help protect your patients?

9 out of 10 babies today lack the key beneficial bacteria B. infantis EVCOO1. Evivo is the only clinically-proven baby probiotic of its kind that restores B infantis to the infant gut microbiome and reduces antibiotic-resistant genes from the start. 

  • Recommend Evivo to your patients on day one to replace bad bacteria with good bacteria, setting them on the path for life-long health. 
  • When the need arises to prescribe infant antibiotics, follow-up with the recommendation of Evivo to reduce antibiotic resistance genes and restore good bacteria to the infant's gut.

View our Webinar:

Early-life Probiotic Feeding to Combat Antibiotic Resistance

Speak to a Sales Director